Your legacy can help bring an end to CMT. Learn how a planned gift can make an impact for generations to come.
The 2020 Summer CMTA Report
…CMT Patients Turn to Telemedicine For Treatment During Pandemic Six Centers of Excellence Surveyed Connecting Our Community Online Taking the Toronto Branch Online Intubation and Mechanical Ventilation Calling All Dreamers!…
Encouraging News in CMT Research from CMTA-STAR Alliance Partner Alesta Therapeutics
…working on a treatment to tackle the nerve damage caused by tRNA synthetase gene mutations in certain types of CMT. According to the company, their therapy, ALE2, works by shutting…
Inherited Neuropathies Consortium Study 6611: Charcot-Marie-Tooth disease Infant Scale
…study, led by INC, aims to develop and validate the Charcot-Marie-Tooth Infant Scale (CMTInfS) to assess disease severity in infants and toddlers. Research suggests that treatment to slow disease progression…
CMTA-STAR Alliance Partner NMD Pharma Publishes Transformative Study on Charcot-Marie-Tooth Disease
…According to the company, treatment with the company’s novel CIC-1 inhibitor NMD670 improved muscle function in preclinical models, marking a critical step toward developing therapies for the CMT community. “This…
CMTA Announces New Center of Excellence at Duke University Hospital
The Charcot-Marie-Tooth Association (CMTA), the world’s largest philanthropic funder of research aimed at bringing treatments to patients and improving the lives of those living with Charcot-Marie-Tooth disease (CMT), is thrilled…
SYNAPSE-CMT: Join the Journey to Advance CMT Research
…for people living with CMT. The hope is that this treatment will improve your strength, endurance, and overall daily functioning. By joining the study, you’ll play a critical role in…
CMTA Announces New Center of Excellence in Kentucky
The Charcot-Marie-Tooth Association (CMTA), the world’s largest philanthropic funder of research aimed at bringing treatments to patients and improving the lives of those living with Charcot-Marie-Tooth disease (CMT), is excited…
Project Foresee: The Path to Cure CMT4C
…an update on November 1, 2023 (see AAV9-mediated SH3TC2 gene replacement therapy targeted to Schwann cells for the treatment of CMT4C). The results from this research provide the level of…
Advancements in CMT1A and CMT1B Research Highlight CMTA’s Impact
…the Health Sciences (USU). The paper, published in Cellular and Molecular Life Sciences, reports encouraging advancements in the search for treatments for CMT1A and CMT1B. Building on his previous CMTA-funded…
Gene Therapy for CMT1A, 1B, and X1: Progress in Nanoparticles
…to reach where they are needed: Schwann cells. This testing will help the team figure out the best way to deliver the treatment in the future. The next phase involves…